Hi, I'm a graduate student, college of nursing, chungnam national university in Daejeon.

The topic of my thesis is "Quality Assessment of Tools for Evaluating Acute Postoperative Pain." I have conducted a quality assessment of pain evaluation tools based on the COSMIN guidelines for the quality of measurement tools. I have a few questions regarding this process.

  • The COSMIN guidelines for PROM quality assessment are specifically for self-reported measurement tools. Is it appropriate to apply these guidelines to pain evaluation tools, which include not only self-reported measures but also observational tools used by healthcare professionals that consider behavioral indicators and physiological measures?
  • According to the COSMIN guidelines, the first step is the risk of bias assessment for individual studies. The guidelines state that there is no need to assess other measurement properties if content validity and structural validity are not reported in the individual studies. If most of the extracted studies do not report these validities, is it meaningful to proceed with the COSMIN quality assessment steps?
  • For individual studies that do not report most of the measurement properties, would it be acceptable to conduct a COSMIN quality assessment only for the studies focused on tool development and validity based on the researcher's discretion, and for other studies using the tool, analyze only the number of studies reporting reliability and validity without conducting a COSMIN quality assessment?
  • If there are multiple individual studies applying the same tool, should each study be assessed for quality separately according to the COSMIN guidelines, or should the assessment focus on the tool itself across multiple studies?
  • Thank you.

    More Nagyeong Kim's questions See All
    Similar questions and discussions